Devices › Closed antineoplastic and hazardous drug reconstitution and transfer system
Device brand name · Closed antineoplastic and hazardous drug reconstitution and transfer system
ChemoClave Vented Bag Spike: medical device reports filed with FDA
162 reports name it, 2019–2026. Manufacturer given most often on reports: Icu Medical De Mexico S De R L De C V. Product code ONB.
- 162
- device reports naming the brand
- 0% of all MAUDE reports · about 22 a year
- 42
- reports, 12 months to August 2026
- 58 in the 12 months before
- 100%
- classified as malfunction
- 96.4% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 162 reports that name the brand "ChemoClave Vented Bag Spike" (closed antineoplastic and hazardous drug reconstitution and transfer system), received between February 2019 and August 2026; the manufacturer given most often on reports is Icu Medical De Mexico S De R L De C V. Spellings of one product vary from report to report.
42 reports arrived in the 12 months to August 2026, down 28% from 58 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (100%); across all closed antineoplastic and hazardous drug reconstitution and transfer system reports (product code ONB) death is recorded in 0% and malfunction in 96.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are fluid/blood leak (56.8%), no flow (22.8%) and failure to infuse (9.3%). The patient problems coded most often are chemical exposure. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 4,837 reports carrying product code ONB. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Fluid/blood leak | 92 | 56.8% | 23.4% |
| No flow | 37 | 22.8% | 2.6% |
| Failure to infuse | 15 | 9.3% | 0.4% |
| Air/gas in device | 10 | 6.2% | 1.3% |
| Particulates | 5 | 3.1% | 2.3% |
| Breakthe device broke | 4 | 2.5% | 5.1% |
| Device contamination with chemical or other material | 3 | 1.9% | 7.9% |
| Crackthe device cracked | 2 | 1.2% | 1% |
| Blocked connection | 1 | 0.6% | 0% |
| Collapse | 1 | 0.6% | 0% |
| Excess flow or over-infusion | 1 | 0.6% | 0% |
| Infusion or flow problema problem with flow or infusion | 1 | 0.6% | 2.3% |
| Material deformation | 1 | 0.6% | 0% |
| Material separation | 1 | 0.6% | 2.9% |
| Material split, cut or torn | 1 | 0.6% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Chemical exposure | 6 | 3.7% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | ChemoClave Vented Bag Spike | Product code ONB | All MAUDE reports |
|---|---|---|---|
| Reports | 162 | 4,837 | 26,136,888 |
| Share of that pool | — | 3.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 0% | 3.1% | 36.2% |
| Classified as malfunction | 100% | 96.4% | 62.3% |
| Filed by the manufacturer | 100% | 88.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code ONB
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Spinning Spiros Closed Male Luer, Red Cap | 468 | 63 | 0% |
| ICU Medical | 288 | 55 | 0.3% |
| Unspecified BD Infusion Set | 1,535 | 484 | 0.2% |
| Cadd Legacy Pump | 1,160 | 4 | 0.2% |
| Administration Set | 419 | 2 | 1.4% |
| Alaris | 1,229 | 79 | 1.1% |
| BD alaris pump infusion set | 180 | 55 | 1.1% |
| Tego Connector | 1,179 | 212 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about ChemoClave Vented Bag Spike reports
How many FDA reports name ChemoClave Vented Bag Spike?
162 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 42 in the latest 12 months.
What kinds of events are reported?
malfunction (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
fluid/blood leak (56.8%), no flow (22.8%), failure to infuse (9.3%), air/gas in device (6.2%) and particulates (3.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that ChemoClave Vented Bag Spike was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.